1. Home
  2. XNCR vs TREE Comparison

XNCR vs TREE Comparison

Compare XNCR & TREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • TREE
  • Stock Information
  • Founded
  • XNCR 1997
  • TREE 1996
  • Country
  • XNCR United States
  • TREE United States
  • Employees
  • XNCR N/A
  • TREE N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • TREE Finance: Consumer Services
  • Sector
  • XNCR Health Care
  • TREE Finance
  • Exchange
  • XNCR Nasdaq
  • TREE Nasdaq
  • Market Cap
  • XNCR 579.3M
  • TREE 482.0M
  • IPO Year
  • XNCR 2013
  • TREE N/A
  • Fundamental
  • Price
  • XNCR $7.90
  • TREE $37.20
  • Analyst Decision
  • XNCR Buy
  • TREE Buy
  • Analyst Count
  • XNCR 7
  • TREE 8
  • Target Price
  • XNCR $27.50
  • TREE $64.13
  • AVG Volume (30 Days)
  • XNCR 800.2K
  • TREE 247.4K
  • Earning Date
  • XNCR 08-04-2025
  • TREE 07-24-2025
  • Dividend Yield
  • XNCR N/A
  • TREE N/A
  • EPS Growth
  • XNCR N/A
  • TREE N/A
  • EPS
  • XNCR N/A
  • TREE N/A
  • Revenue
  • XNCR $127,228,000.00
  • TREE $972,179,000.00
  • Revenue This Year
  • XNCR N/A
  • TREE $11.20
  • Revenue Next Year
  • XNCR $28.84
  • TREE $7.39
  • P/E Ratio
  • XNCR N/A
  • TREE N/A
  • Revenue Growth
  • XNCR N/A
  • TREE 51.96
  • 52 Week Low
  • XNCR $7.16
  • TREE $33.50
  • 52 Week High
  • XNCR $27.24
  • TREE $62.49
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 44.24
  • TREE 53.69
  • Support Level
  • XNCR $7.88
  • TREE $35.36
  • Resistance Level
  • XNCR $8.80
  • TREE $36.95
  • Average True Range (ATR)
  • XNCR 0.53
  • TREE 1.25
  • MACD
  • XNCR -0.05
  • TREE 0.52
  • Stochastic Oscillator
  • XNCR 22.41
  • TREE 94.20

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About TREE LendingTree Inc.

LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.

Share on Social Networks: